XML 32 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 8,522,086 $ 13,353,543
Investment securities - available for sale, at fair value 10,290,378 14,257,998
Accrued interest receivable on investment securities 26,971 68,309
Advances and deposits on clinical programs and other current assets 1,271,670 451,293
Total current assets 20,111,105 28,131,143
Property and equipment (at cost, less accumulated depreciation of $3,059,285 and $2,968,259, respectively) 430,046 184,627
Other assets:    
In-process research and development, net 15,736,491 15,736,491
Goodwill 1,976,101 1,976,101
Operating lease right-of-use assets, net 1,521,869
Other intangible assets, net 397,805 568,292
Deposits and other assets 390,433 258,933
Total other assets 20,022,699 18,539,817
Total assets 40,563,850 46,855,587
Current liabilities:    
Accounts payable - trade 3,935,750 3,020,638
Other accrued liabilities 2,396,773 2,585,898
Notes payable - current portion, net of deferred financing costs 579,480
Operating lease liability - current portion 377,005
Deferred revenue - current portion 500,000 500,000
Total current liabilities 7,789,008 6,106,536
Earn-out milestone liability 5,818,843 8,907,664
Note Payable, net of deferred financing costs 9,126,739 9,417,037
Operating lease liability - non-current portion 1,244,710
Deferred revenue - non-current portion 1,125,000 1,500,000
Other liabilities - non-current 63,278
Total liabilities 25,104,300 25,994,515
Commitments and contingencies
Stockholders' equity:    
Preferred Stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at September 30, 2019 and December 31, 2018)
Common stock - $0.01 par value (112,500,000 shares authorized; 22,002,752 and 18,832,168 shares issued at September 30, 2019 and December 31, 2018, respectively, and 22,002,418 and 18,831,834 shares outstanding at September 30, 2019 and December 31, 2018, respectively) 220,028 188,322
Additional paid-in capital 302,704,656 294,393,313
Accumulated other comprehensive gain 34,075 29,872
Accumulated deficit (287,414,021) (273,665,247)
Total stockholders' equity before treasury stock 15,544,738 20,946,260
Treasury stock, at cost (334 shares at September 30, 2019 and December 31, 2018) (85,188) (85,188)
Total stockholders' equity 15,459,550 20,861,072
Total liabilities and stockholders' equity $ 40,563,850 $ 46,855,587